KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $306,789 | 0.0% | 1,689 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $306,789 | -33.3% | 1,689 | -27.9% | 0.00% | -33.3% |
| Q4 2022 | $460,203 | -0.2% | 2,342 | +14.2% | 0.00% | 0.0% |
| Q3 2022 | $461,000 | +35.2% | 2,050 | -24.0% | 0.00% | +50.0% |
| Q2 2022 | $341,000 | +29.7% | 2,698 | +4.2% | 0.00% | +100.0% |
| Q4 2020 | $263,000 | -8.4% | 2,590 | -30.4% | 0.00% | -50.0% |
| Q3 2020 | $287,000 | -7.4% | 3,720 | +33.6% | 0.00% | 0.0% |
| Q2 2020 | $310,000 | +89.0% | 2,785 | +27.2% | 0.00% | +100.0% |
| Q1 2020 | $164,000 | 0.0% | 2,190 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $164,000 | – | 2,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |